NCT06577090Phase 2Active not recruiting

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

Study sponsor: Skye Bioscience, Inc. · SKYE

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-11-20Estimated
Enrollment · participants136Actual
Source updated2026-01-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Percent change in body weight (main study) Measure: Nature, frequency and severity of AEs (study extension) Measure: Part C - The nature, frequency, and severity of treatment-emergent adverse events (TEAEs), including serious adverse events (SAEs) and adverse events of special interest (AESIs). After: Measure: Percent change in body weight (main study) Measure: Nature, frequency and severity of AEs (study extension).

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 152 participants (planned). After: 136 participants (actual).

Check registry source

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Percent change in body weight. After: Measure: Percent change in body weight (main study) Measure: Nature, frequency and severity of AEs (study extension) Measure: Part C - The nature, frequency, and severity of treatment-emergent adverse events (TEAEs), including serious adverse events (SAEs) and adverse events of special interest (AESIs).

Planned enrollment increased by 32 participants

Before: 120 participants (planned). After: 152 participants (planned).

Primary completion date changed

Before: Aug 2025. After: 20 Nov 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview